Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data.
Guenter NiegischMarc-Oliver GrimmFraence HardtstockJulia KriegerAlexandra StarryUlrike OsowskiBarthold DeitersUlf MaywaldThomas WilkeMairead KearneyPublished in: Journal of medical economics (2024)
The study shows that mUC is associated with significant HCRU and costs across different types of 1 L systemic therapy.